Introduction
Nicotine addiction remains a primary health concern as tobacco smoking remains the number one cause of preventable death in America. At the same time, America is still facing the threat of the opioid epidemic. While the prevalence of smoking combustible cigarettes or electronic nicotine delivery systems (ENDS) in the USA varies between 12–35%, the smoking rates among the opioid use disorder (OUD) population is 74-97% 1. We examined changes in brain reward mechanisms in which co-use of nicotine and opioids may result in enhanced reward and/or reinforcement.
Methods
Adult male and female α4-mCherryα6-GFP mice (C57BL/6J) were used in conditioned place preference (CPP) and microscopy assays to examine reward-related behavior and nicotinic acetylcholine receptor (nAChR) upregulation following treatments with saline, nicotine, morphine, or nicotine plus morphine. Following this, separate mice were trained in e-Vape® self-administration assays to examine morphine’s impact on nicotine reinforcement.
Results
We observed that nicotine and morphine co-exposure in a conditioned place preference (CPP) assay did not produce enhanced reward-related behavior when compared to nicotine or morphine alone. In parallel we observed co-exposure reduced nicotine-induced upregulation of nAChRs on ventral tegmental area (VTA) dopamine and GABA neurons. Additionally, we observed that concurrent morphine exposure reduced nicotine (plus menthol) vapor self-administration in male and female mice.
Conclusions
While nicotine use is high among OUD individuals, our CPP assays suggest co-exposure not only fails to enhance reward-related behavior but also reduces nicotine-induced changes in VTA neurobiology. Our self-administration assays suggest that morphine exposure during nicotine acquisition reduces nicotine reinforcement-related behavior.
Implications
While some may postulate that the co-use of opioids and nicotine may be driven by reward-related mechanisms, our data indicate that opioid exposure may hinder nicotine intake due to reduced upregulation of nAChRs critical for nicotine reward and reinforcement. Thus, the high co-use in OUD individuals may be a result of other mechanisms and this warrants further investigations into nicotine and opioid co-use.